Kementec Solutions A/S: Financial statements 2014
CVR: 25806735
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Kementec Solutions A/S (CVR 25806735) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 10,501,512 and a net result of DKK 1,654,784 compared with DKK 2,384,646 the year before. That is a decrease of 8.4% compared with the year before. Equity in the 2014 report amounted to DKK 5,071,243. The solvency ratio was 52.1%.
- Gross Profit
- DKK 10,501,512
- Profit/Loss
- DKK 1,654,784
- Equity
- DKK 5,071,243
- Total Assets
- DKK 9,727,021
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 10.5 mio. | 1.7 mio. | 5.1 mio. | - |
| 2013 | - | 11.5 mio. | 2.4 mio. | 4.9 mio. | - |
| 2012 | - | 10.4 mio. | 1.1 mio. | 3.6 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
Kementec Solutions A/S has published its annual report for 2013. Gross profit came to DKK 11,469,739, and the net result was DKK 2,384,646.
About Kementec Solutions A/S
Kementec Solutions A/S is a Danish company of the type Aktieselskab based in Taastrup, founded in 2000. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named KEM-EN-TEC DIAGNOSTICS A/S. The management consists of Elaine Antonette Lundberg and Tobias Greve-Vilby. The board consists of Frank Vitzthum (chair), Christian Moraeno Dreher and Ute Salzbrenner. The company is owned by R-Biopharm AG. The company has 20 employees (2026). In 2025, the company reported a gross profit of DKK 18,706,173 and a net result of DKK 2,269,339 compared with DKK 1,565,137 the year before. Equity in the 2025 report amounted to DKK 25,366,459.